The ease of acquiring prior authorizations for a new formulary drug plays a part in evaluating oncology drugs that are new to the market.
Andrea Iannucci, PharmD, BCOP
Advertisement
Assistant Chief Pharmacist, UC Davis Health
Articles by Andrea Iannucci, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues
2
Kerry Rogers, MD, on BTK Inhibitor Selection and Tolerability in CLL
3
FDA Expands Pembrolizumab-Enfortumab for Muscle-Invasive Bladder Cancer
4
FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma
5